Activated PI3K delta syndrome: Difference between revisions
CSV import |
CSV import |
||
| Line 37: | Line 37: | ||
[[Category:Immunodeficiency disorders]] | [[Category:Immunodeficiency disorders]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
<gallery> | |||
File:Autosomal_dominant_-_en.svg|Autosomal dominant inheritance pattern | |||
File:PI3kinase.png|Structure of PI3 kinase | |||
File:Amoxicillin.svg|Chemical structure of Amoxicillin | |||
</gallery> | |||
Revision as of 01:41, 18 February 2025
Activated PI3K Delta Syndrome


Activated PI3K Delta Syndrome (APDS) is a rare primary immunodeficiency disorder characterized by mutations in the PIK3CD gene, which encodes the p110_ catalytic subunit of phosphoinositide 3-kinase (PI3K). This condition leads to immune dysregulation, recurrent infections, and increased susceptibility to lymphoproliferative disorders.
Pathophysiology
APDS is caused by gain-of-function mutations in the PIK3CD gene, resulting in hyperactivation of the PI3K delta pathway. This hyperactivation affects the development and function of B cells, T cells, and natural killer cells, leading to immune system dysfunction. The PI3K delta pathway is crucial for the regulation of immune cell signaling, and its dysregulation can result in impaired immune responses and increased risk of autoimmunity.
Clinical Features
Patients with APDS typically present with recurrent sinopulmonary infections, lymphadenopathy, and hepatosplenomegaly. They may also develop autoimmune disorders and have an increased risk of lymphoma. The condition is often diagnosed in childhood, but symptoms can vary widely among individuals.
Diagnosis
Diagnosis of APDS involves genetic testing to identify mutations in the PIK3CD gene. Immunological assessments may reveal abnormalities in B and T cell populations, as well as impaired antibody responses. Clinical evaluation of recurrent infections and lymphoproliferative symptoms is also essential for diagnosis.
Treatment
Management of APDS includes the use of antibiotics to prevent and treat infections, such as amoxicillin. Immunoglobulin replacement therapy may be necessary for patients with significant antibody deficiencies. Targeted therapies, such as PI3K inhibitors, are being investigated as potential treatments to address the underlying immune dysregulation.
Related Pages
Gallery
-
Structure of amoxicillin
-
Autosomal dominant inheritance pattern
-
Structure of PI3 kinase
-
Chemical structure of Amoxicillin